All 12 (100%) individuals in the CF/MABSC group and 10/15 (67.7%) in the CF/NTM- group had increased CD3+ or CD19+ lymphoblast formation upon stimulation of their PBMC with MABSC lysate (Table 1). This evidence concerns the gene CD19 and cystic fibrosis.